Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 25 Carcinoma, Non-Small-Cell Lung 14 Squamous Cell Carcinoma of Head and Neck 11 Melanoma 10 Breast Neoplasms 10 Urinary Bladder Neoplasms 9 Colorectal Neoplasms 9 Lung Neoplasms 6 Cholangiocarcinoma 6 Carcinoma, Renal Cell 6 Biliary Tract Neoplasms 6 Adenocarcinoma Of Esophagus 6 Ovarian Neoplasms 5 Liver Neoplasms 5 Diabetes Mellitus, Insulin-Dependent, 12 5 Uterine Cervical Neoplasms 4 Stomach Neoplasms 4 Small Cell Lung Carcinoma 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Mesothelioma, Malignant 4 Head and Neck Neoplasms 4 Neoplasm Metastasis 3 Mesothelioma 3 Kidney Neoplasms 3 Fallopian Tube Neoplasms 3 Endometrial Neoplasms 3 Carcinoma, Transitional Cell 3 Vulvar Neoplasms 2 Vaginal Neoplasms 2

Interventions

tremelimumab 1 durvalumab 1 Specimen Handling 1 Radiosurgery 1 Medical Marijuana 1 Heavy Ion Radiotherapy 1 Gemcitabine 1 Chemoradiotherapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Pancreatic Cancer Non-resectable × tremelimumab × Clear all

NCT04156087 2024-09-19

MIMIPAC

University Hospital, Gasthuisberg

Phase 2 Completed

Gastrointestinal

Pancreatic Cancer Non-resectable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡